$47.97
1.523.27%
Last update: Nov 9, 4:00 PM
AnaptysBio Inc
ANABNASDAQ
The average analyst price target for AnaptysBio is $69.81, 45.5% above the current price. Of 14 analysts, 12 rate it Buy and 2 Hold. Targets range from $20 to $100. The latest change came on Sep 30, 2026, when JP Morgan lowered its price target on AnaptysBio from $70 to $60 and kept an Overweight rating.
Price Target Range — 12 Quarters
Analyst Consensus — 14 Analysts
Rating Trend — Last 9 Months
